BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28051126)

  • 21. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.
    Song BJ; Akbar M; Jo I; Hardwick JP; Abdelmegeed MA
    Adv Pharmacol; 2015; 74():303-72. PubMed ID: 26233911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.
    Seth RK; Das S; Dattaroy D; Chandrashekaran V; Alhasson F; Michelotti G; Nagarkatti M; Nagarkatti P; Diehl AM; Bell PD; Liedtke W; Chatterjee S
    Free Radic Biol Med; 2017 Jan; 102():260-273. PubMed ID: 27913210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
    Kim TH; Banini BA; Asumda FZ; Campbell NA; Hu C; Moser CD; Shire AM; Han S; Ma C; Krishnan A; Mounajjed T; White TA; Gores GJ; LeBrasseur NK; Charlton MR; Roberts LR
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G333-G344. PubMed ID: 32683952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
    Alhasson F; Dattaroy D; Das S; Chandrashekaran V; Seth RK; Schnellmann RG; Chatterjee S
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F85-F101. PubMed ID: 26447219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition.
    Jian T; Ao X; Wu Y; Lv H; Ma L; Zhao L; Tong B; Ren B; Chen J; Li W
    Biomed Pharmacother; 2017 Jul; 91():229-237. PubMed ID: 28458161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
    Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
    Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy Protects against CYP2E1/Chronic Ethanol-Induced Hepatotoxicity.
    Lu Y; Cederbaum AI
    Biomolecules; 2015 Oct; 5(4):2659-74. PubMed ID: 26501338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage.
    Morgan K; French SW; Morgan TR
    Hepatology; 2002 Jul; 36(1):122-34. PubMed ID: 12085356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
    Chalasani N; Gorski JC; Asghar MS; Asghar A; Foresman B; Hall SD; Crabb DW
    Hepatology; 2003 Mar; 37(3):544-50. PubMed ID: 12601351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol.
    Kim DK; Kim YH; Jang HH; Park J; Kim JR; Koh M; Jeong WI; Koo SH; Park TS; Yun CH; Park SB; Chiang JYL; Lee CH; Choi HS
    Gut; 2013 Jul; 62(7):1044-54. PubMed ID: 23023167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
    Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
    Cui WX; Yang J; Chen XQ; Mao Q; Wei XL; Wen XD; Wang Q
    Am J Chin Med; 2013; 41(3):487-502. PubMed ID: 23711137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress caused by a SOD1 deficiency ameliorates thioacetamide-triggered cell death via CYP2E1 inhibition but stimulates liver steatosis.
    Shirato T; Homma T; Lee J; Kurahashi T; Fujii J
    Arch Toxicol; 2017 Mar; 91(3):1319-1333. PubMed ID: 27349771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.
    Seth RK; Das S; Pourhoseini S; Dattaroy D; Igwe S; Ray JB; Fan D; Michelotti GA; Diehl AM; Chatterjee S
    J Pharmacol Exp Ther; 2015 Jan; 352(1):77-89. PubMed ID: 25347994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.
    Abdelmegeed MA; Ha SK; Choi Y; Akbar M; Song BJ
    Curr Mol Pharmacol; 2017; 10(3):207-225. PubMed ID: 26278393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):973-83. PubMed ID: 19307976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice.
    Seth RK; Kumar A; Das S; Kadiiska MB; Michelotti G; Diehl AM; Chatterjee S
    Toxicol Sci; 2013 Aug; 134(2):291-303. PubMed ID: 23640861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
    Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis.
    Das S; Seth RK; Kumar A; Kadiiska MB; Michelotti G; Diehl AM; Chatterjee S
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G950-63. PubMed ID: 24157968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.